You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CCI-779

Showing 1 - 25 of 183
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Rochester, Madison (CCI-779,

Completed
Has Results
  • Clear Cell Renal Cell Carcinoma
  • +2 more
  • Rochester, Minnesota
  • +1 more
Jan 12, 2022

Diffuse Intrinsic Pontine Glioma Trial in Houston (Radiation Therapy, Temsirolimus, Vorinostat)

Active, not recruiting
  • Diffuse Intrinsic Pontine Glioma
  • Radiation Therapy
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 5, 2022

Prostate Cancer, Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer Trial in Baltimore, Buffalo (drug, other,

Terminated
  • Prostate Cancer
  • +4 more
  • Baltimore, Maryland
  • +1 more
Sep 30, 2022

Advanced Cancers Trial in Houston (Temsirolimus, Metformin)

Active, not recruiting
  • Advanced Cancers
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Oct 11, 2022

Advanced Cancer Trial in Houston (Temsirolimus, Bevacizumab, Paclitaxel)

Active, not recruiting
  • Advanced Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Oct 11, 2022

Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Diffuse Astrocytoma Trial in New York (other, drug,

Completed
Has Results
  • Adult Anaplastic Astrocytoma
  • +8 more
  • Laboratory Biomarker Analysis
  • +3 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jun 28, 2021

Advanced Malignant Tumor, Castleman Disease, Digestive System Carcinoma Trial in Houston (biological, other, drug)

Active, not recruiting
  • Advanced Malignant Neoplasm
  • +38 more
  • Bevacizumab
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 18, 2022

Kidney Cancer Trial in Houston (Pazopanib, Temsirolimus, Quality of Life Assessment)

Completed
Has Results
  • Kidney Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Aug 24, 2021

Recurrent Breast Carcinoma, Stage III Breast Cancer AJCC v7, Stage IIIA Breast Cancer AJCC v7 Trial in Chicago, Saint Louis

Completed
Has Results
  • Recurrent Breast Carcinoma
  • +5 more
  • Chicago, Illinois
  • +1 more
Feb 13, 2020

Advanced Cancer Trial in Houston (Sirolimus, Vorinostat, Everolimus)

Unknown status
  • Advanced Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Apr 10, 2020

PRETEXT Stage 1 Hepatoblastoma, PRETEXT Stage 2 Hepatoblastoma, PRETEXT Stage 3 Hepatoblastoma Trial in Worldwide (drug, other,

Active, not recruiting
Has Results
  • PRETEXT Stage 1 Hepatoblastoma
  • +3 more
  • Birmingham, Alabama
  • +208 more
Jan 25, 2023

Hormone-Resistant Prostate Cancer, Prostate Adenocarcinoma, Recurrent Prostate Carcinoma Trial in United States (biological,

Completed
Has Results
  • Hormone-Resistant Prostate Cancer
  • +3 more
  • Cixutumumab
  • +2 more
  • Chicago, Illinois
  • +3 more
May 21, 2019

Prostate Cancer Trial in Cleveland, Willoughby Hills (drug, biological, genetic, other)

Completed
Has Results
  • Prostate Cancer
  • Cleveland, Ohio
  • +2 more
Aug 19, 2019

Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma Trial in United States

Active, not recruiting
Has Results
  • Endometrial Adenocarcinoma
  • +9 more
  • Bevacizumab
  • +5 more
  • Phoenix, Arizona
  • +232 more
Jan 12, 2023

Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid

Active, not recruiting
  • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
  • +9 more
  • Sewell, New Jersey
  • +4 more
Dec 13, 2022

Advanced Cancer Trial in Houston (Doxil, Bevacizumab, Temsirolimus)

Completed
  • Advanced Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Apr 9, 2019

Alveolar Rhabdomyosarcoma, Botryoid-Type Embryonal Rhabdomyosarcoma, Embryonal Rhabdomyosarcoma Trial in Worldwide (drug,

Suspended
  • Alveolar Rhabdomyosarcoma
  • +5 more
  • Birmingham, Alabama
  • +386 more
Aug 18, 2022

Recurrent Endometrial Carcinoma Trial in United States (bevacizumab, temsirolimus)

Completed
Has Results
  • Recurrent Endometrial Carcinoma
  • Hartford, Connecticut
  • +40 more
Jul 19, 2019

Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b) Trial

Completed
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • +13 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Feb 2, 2023

Biomechanics Based Prediction of Preterm Delivery

Completed
  • Preterm Delivery
  • Pregnolia System
  • Leuven, Belgium
  • +12 more
Dec 8, 2022

PICS: Subtitle Cardiac Dysfunction in Older Sepsis Survivors

Active, not recruiting
  • Sepsis
  • Blood collection
  • +6 more
  • Gainesville, Florida
    UF Health Shands Hospital
Oct 24, 2022

Dihydropyridine Calcium Channel Inhibitors on Respiratory Gas

Completed
  • Hypoxia
  • dihydropyridine calcium channel inhibitors use
  • Caen, Normandie, France
    Caen University Hospital, Department of Pharmacology
Sep 8, 2022

Virtual Ileostomy Versus Conventional Loop Ileostomy

Recruiting
  • Rectal Neoplasms
  • VI
  • DI
  • Chongqing, China
    Daping Hospital, Third Military Medical University
Aug 15, 2023

Rectal Tumors Trial in Chongqing (Virtual ileostomy, Diverting ileostomy)

Not yet recruiting
  • Rectal Neoplasms
  • Virtual ileostomy
  • Diverting ileostomy
  • Chongqing, China
  • +1 more
Aug 8, 2023

Brain and CNS Tumors Trial in United States (temsirolimus)

Completed
  • Brain and Central Nervous System Tumors
  • Los Angeles, California
  • +9 more
Jun 22, 2018